Phase 2 trial of immunotherapy in tumors with CDK12 inactivation (IMPACT): Results from cohort A of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) receiving dual immune checkpoint inhibition (ICI) Meeting Abstract
| Authors: | Alva, A. S.; Li, J.; Chou, J.; Reimers, M. A.; McKay, R. R.; Zhang, J.; Daignault-Newton, S.; Palmbos, P. L.; Reichert, Z. R.; Cieslik, M.; Chinnaiyan, A.; Abida, W. |
| Abstract Title: | Phase 2 trial of immunotherapy in tumors with CDK12 inactivation (IMPACT): Results from cohort A of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) receiving dual immune checkpoint inhibition (ICI) |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900105 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.103 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 103 -- Meeting was conducted online as well as in person -- Source: Wos |
